A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection

Summary

This is a Phase 1, randomized, placebo-controlled study, enrolling approximately 38 healthy adult subjects (18-65 yrs). The purpose of this study is to evaluate the safety, tolerability and PK of single ascending dose of 9MW1911 administered intravenously (IV) in healthy adult volunteers. All subjects will be followed up for safety from the time of Informed Consent through 113 days post dose.

Timeline

Start

2022-01-21

Primary completion

2022-07-03

Completion

2022-10-28

Drugs

Indications